Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of MAb 806, a novel monoclonal antibody directed to the receptor. Conference Paper uri icon

authors

  • Mishima, K
  • Johns, TG
  • Luwor, RB
  • Scott, AM
  • Stockert, E
  • Jungbluth, AA
  • Old, LJ
  • Huang, HS
  • Cavenee, WK

publication date

  • November 1, 2001